Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, semaglutide can cause heartburn. It slows the rate at which the stomach empties, and that delay can push acid back towards the oesophagus — particularly in the first few weeks of treatment or after a dose increase. For most people it is mild and short-lived, but knowing why it happens and what settles it makes it far easier to manage. These are prescription-only medicines; a prescriber assesses whether they are suitable for you before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide works partly by activating GLP-1 receptors in the gut. One direct consequence is that the stomach empties more slowly than usual, this is intentional, because slower emptying prolongs the feeling of fullness. The trade-off is that food and gastric acid spend longer in the stomach, which raises pressure on the lower oesophageal sphincter. When that pressure tips the balance, acid travels upward and produces the burning sensation most people recognise as heartburn.
It is a predictable physiological effect rather than a signal that something has gone wrong. The NHS medicines page for semaglutide lists indigestion, burping and reflux among the common side effects, and the clinical trial programme echoed this: gastrointestinal complaints were the most frequently reported category across participants. So if you are a few days into Wegovy and finding yourself reaching for antacids, you can read more about whether semaglutide can give you heartburn and why it is one of the questions our prescribers hear most regularly.
A few practical details matter here. Eating large meals makes reflux more likely because volume amplifies the pressure problem. High-fat meals delay gastric emptying further, compounding the effect. Lying down within two to three hours of eating is another common trigger. None of these are failures on your part; they are just patterns worth recognising and adjusting while your body acclimates.
For the majority of people, heartburn on semaglutide follows a pattern: it arrives with a new dose and fades over the following one to two weeks as the gut adapts to the changed emptying rate. That adaptation window is the most important thing to hold onto when symptoms feel discouraging.
The adjustments that tend to help are straightforward. Smaller, more frequent meals reduce the volume pressing against the sphincter. Sitting upright for at least two hours after eating gives gravity a chance to keep acid where it belongs. Cutting back on coffee, alcohol, carbonated drinks and spicy food (even temporarily) removes the triggers that irritate an already-sensitised oesophagus. Raising the head of the bed by a few centimetres can make a real difference overnight.
Over-the-counter antacids are used by many people during this settling-in period. Whether they are appropriate alongside your other medications is a question for your prescriber or pharmacist, because some antacids interact with other oral medicines, including the timing-sensitive oral contraceptive pill. For broader context on what to expect across the full side-effect profile, the Wegovy side effects overview covers the complete picture. If you are weighing up the treatment more broadly, the Wegovy treatment page explains how the medicine is used within a structured programme.
Ordinary reflux and the serious complications that can occur on GLP-1 medicines are genuinely different in character, and distinguishing between them matters. Heartburn is a burning sensation in the chest or throat. What needs urgent assessment is something else: severe, persistent pain in the upper abdomen or the centre of the stomach, especially if it radiates to the back, with or without vomiting.
In January 2026 the MHRA issued a Drug Safety Update confirming that acute pancreatitis is a known, infrequent but potentially serious side effect of GLP-1 receptor agonist medicines. The update specifically asked patients and clinicians to be alert to the symptom pattern described above. You can report any suspected side effects (or raise concerns about the medicines themselves) through the MHRA Yellow Card scheme. If you experience the severe pain pattern, stop eating and drinking and seek medical help the same day; do not wait to see if it settles overnight as ordinary reflux might.
Gallbladder symptoms are another category to be aware of: sudden sharp pain in the upper-right abdomen, particularly after eating, can indicate gallstones, which occur at slightly higher rates in people losing weight rapidly on GLP-1 therapy. Again, this is different in location and character from typical acid reflux.
The decision most people face is whether their heartburn is manageable with simple adjustments, whether the dose schedule needs reviewing, or whether something more needs looking into. That is not a judgment call to make alone. Heartburn severe enough to affect eating or sleep, heartburn that has not improved after a couple of weeks, or any symptom pattern that feels out of the ordinary for reflux should all be raised with a clinician.
At nume, every repeat order involves a clinical review before anything is dispensed. If heartburn has been a persistent issue, that is exactly the right moment to flag it. For people still considering starting treatment and wondering whether Wegovy is the right fit, the free consultation is where our prescribers assess the full picture, including any digestive history that might affect how you respond. There is also useful context on the why semaglutide causes heartburn page if you want a deeper explanation of the gastric-emptying mechanism, and the Wegovy heartburn page covers the management side in more detail. If you are curious about how cost fits into the overall decision, the Wegovy pricing page sets out what a private prescription realistically involves.
Speak to our prescribers if heartburn is making treatment feel unworkable, adjustments are possible, and that conversation is part of what the aftercare is for.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.